Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could peer buddies and shots keep teens with HIV healthy?

NCT ID NCT06721078

Disease control Sponsor: Africa Health Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study in South Africa tests whether peer support and long-acting injectable HIV medication help teens (ages 12-19) stay virally suppressed and keep up with care. 720 teens living with HIV will take part. The goal is to see if these approaches improve health and retention over 18-24 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
long-acting injectable antiretroviral therapy (ART)
What this could lead to
If successful, this could show that peer support and injectable meds help teens with HIV stay healthy and engaged in care.
What could go wrong
This is an early-stage study with no phase, so results are uncertain. It focuses on a specific group in South Africa, so findings may not apply elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 720 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 19 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 12 - \<19, at enrolment * Living with HIV * Aware of their HIV status * Receiving ART for at least six months * Able to read and/or speak English, isiZulu, Sepedi, Afrikaans, Xhosa, or Sesotho * Willing and able to consent to study activities * Willing and able to get parental consent for study activities * (Stage 1, objective 2 only) Age ≥ 18 years and Caregiver of an adolescent with HIV * (Stage 1, objective 2 only) Age ≥ 18 years and provides clinical services or is a policy maker involved in adolescents with HIV Exclusion Criteria: * Inability to read and/or speak English, isiZulu, Sepedi, Afrikaans, Xhosa, or Sesotho * Severe mental or physical illness preventing participation in informed consent activities.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cato Manor CHC

    RECRUITING

    Durban, KwaZulu-Natal, 4001, South Africa

  • Charlotte Maxeke Hospital

    RECRUITING

    Johannesburg, Gauteng, 2001, South Africa

  • Eerste River Hospital

    NOT_YET_RECRUITING

    Cape Town, Western Cape, 8001, South Africa

  • KT Motubatse CHC

    NOT_YET_RECRUITING

    Pretoria, Gauteng, 0001, South Africa

  • Kgabo CHC

    NOT_YET_RECRUITING

    Pretoria, Gauteng, 0001, South Africa

  • KwaMashu CHC

    RECRUITING

    Durban, KwaZulu-Natal, 4001, South Africa

  • Michael Mapongwana CHC

    NOT_YET_RECRUITING

    Cape Town, Western Cape, 8001, South Africa

  • Mtubatuba CHC

    RECRUITING

    Mtubatuba, KwaZulu-Natal, 3935, South Africa

  • Rahima Moosa Mother and Child Hospital

    RECRUITING

    Johannesburg, Gauteng, 2001, South Africa

  • Somkhele CHC

    RECRUITING

    Mtubatuba, KwaZulu-Natal, 3935, South Africa

  • Soshanguve Block JJ

    NOT_YET_RECRUITING

    Pretoria, Gauteng, 0001, South Africa

  • Soshanguve Block TT

    NOT_YET_RECRUITING

    Pretoria, Gauteng, 0001, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.